Viveve medical, inc. (VIVE)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Cash flows from operating activities:
Net loss

-42,526

-49,981

-36,959

-20,111

-12,426

-6,180

-4,317

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts

1,028

179

-221

0

-

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-8,387

-5,758

Income from discontinued operations

-

-

-

-

-

-

-

-

53

Gain on sale of discontinued operations, net of taxes

-

-

-

-

-

-

-

-

687

Depreciation and amortization

1,177

786

449

111

77

56

66

43

9

Stock-based compensation

2,400

3,035

1,872

1,020

220

184

87

544

148

Fair value of common shares issued

-

256

260

0

-

-

-

-

-

Restricted stock award granted to consultant

-

-

-

-

0

-

-

-

-

Fair value of warrants issued

-

-

-

162

251

137

-

-

-

Fair value of warrants issued to employees for bonuses

-

-

-

-

286

-

-

-

-

Revaluation of fair value of warrant liability

-

-

-

-

-

-52

-62

-

-

Non-cash interest expense

1,577

1,580

1,049

456

197

418

306

-

-

Amortization of operating lease right-of-use assets and accretion of operating lease liabilities

5

-

-

-

-

-

-

-

-

Loss on debt restructuring

-6,705

-

-

-

-

-

-

-

-

Loss from minority interest in limited liability company

-627

-657

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-108

-

-

-

-

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-2

-

-

-

Changes in assets and liabilities:
Change in fair value of warrant and options liabilities

-

-

-

-

-

-

-

-1,617

-808

Change in fair value of convertible notes

-

-

-

-

-

-

-

-2,024

-1,894

Financing costs associated with convertible notes

-

-

-

-

-

-

-

80

530

Non-cash interest expense

-

-

-

-

-

-

-

331

225

Deferred income taxes

-

-

-

-

-

-

-

-

492

Accounts receivable

-3,103

-330

3,901

1,498

587

6

-1

-48

321

Inventory

1,070

1,986

67

1,237

1,438

-97

-71

-56

-72

Prepaid expenses and other current assets

-111

-183

1,675

-162

879

41

243

-58

-66

Other noncurrent assets

-40

-31

66

-2

-18

112

-14

-

-

Accounts payable

-2,386

-805

1,713

1,654

1,016

-551

482

228

-194

Deferred revenue

-

-

-

-

-

-

-

32

186

Accrued and other liabilities

-1,536

2,143

2,419

1,192

1,070

57

-160

161

-36

Other noncurrent liabilities

-599

502

274

0

-

-

-

-

-

Net cash used in operating activities

-31,236

-43,090

-34,853

-18,087

-12,195

-5,991

-3,755

-3,165

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-3,603

Purchase of property and equipment

1,087

2,142

905

256

109

117

4

74

18

Investment in limited liability company

-

-

2,500

0

-

-

-

-

-

Net cash used in investing activities

-1,087

-2,142

-3,405

-256

-109

-117

-4

-

-

Cash flows from financing activities:
Net cash used in investing activities

-

-

-

-

-

-

-

-74

-18

Proceeds from equity financings, net of issuance costs

16,274

53,792

31,565

13,886

16,433

4,204

-

-

-

Transaction costs in connection with note payable

216

-

-

-

-

-

-

-

-

Reverse stock split - cancellation and payout of fractional shares

6

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

31

14

-

-

-

-

-

Proceeds from exercise of Series A and B common warrants

-

-

20

92

3

-

-

-

-

Proceeds from note payable

-

-

29,210

9,910

2,500

2,500

-

-

-

Proceeds from related party convertible bridge notes

-

-

-

-

-

-

-

920

3,605

Repayments of note payable

-

-

10,000

4,833

167

1,631

135

-

-

Proceeds from issuance of common shares from employee stock purchase plan

56

233

76

0

-

-

-

-

-

Proceeds from related party convertible bridge notes

-

-

-

-

-

1,500

3,875

-

-

Net cash provided by financing activities

-

-

-

-

18,769

6,573

3,740

920

3,605

Net cash provided by financing activities

16,108

54,025

50,902

19,069

-

-

-

-

-

Net cash provided by operating activities

-

-

-

-

-

-

-

-

210

Net cash provided by investing activities

-

-

-

-

-

-

-

-

1,000

Net cash provided by discontinued operations

-

-

-

-

-

-

-

-

1,210

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-8

67

Net decrease in cash and cash equivalents

-16,215

8,793

12,644

726

6,465

465

-19

-2,327

1,261

Supplemental disclosure:
Cash paid for interest

2,508

2,673

2,066

803

-

-

-

-

-

Cash paid for interest

-

-

-

-

196

149

141

217

171

Cash paid for income taxes

-

2

-

1

1

1

1

-

-

Supplemental disclosure of cash flow information as of end of period:
Issuance of Series B convertible preferred stock in settlement of dividends

378

-

-

-

-

-

-

-

-

Restricted stock awards granted to employees for 2015 accrued bonuses

-

-

-

246

0

-

-

-

-

Conversion of certain bridge notes and related accrued interest in connection with private placement offering

-

-

-

-

-

1,546

-

-

-

Extinguishment of convertible notes debt and related related accrued interest pursuant to Merger Agreement

-

-

-

-

-

5,397

-

-

-

Extinguishment of warrants pursuant to Merger Agreement

-

-

-

-

-

572

-

-

-

Payable to non-accredited investors in connection with Merger Agreement

-

-

-

-

-

16

-

-

-

Issuance of Series B convertible preferred stock and common stock warrants in connection with debt conversion

35,529

-

-

-

-

-

-

-

-

Issuance of warrants in connection with note payable

-

-

940

350

10

622

-

-

-

Issuance of note payable in settlement of accrued interest

1,226

1,256

495

0

-

-

-

-

-

Net transfer of equipment between inventory and property and equipment

207

257

-

-

-

-

-

-

-

Net transfer of equipment between inventory and property and equipment

-

-

364

99

20

-

61

-

-

Operating cash outflows from operating leases

295

-

-

-

-

-

-

-

-

Right-of-use assets obtained in exchange for operating lease liabilities (upon adoption of ASC 842)

629

-

-

-

-

-

-

-

-